Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Combo pills do not save patients money

Leslie Ramirez, MD
Meds
July 7, 2010
Share
Tweet
Share

Many prescription medicines are actually two or more medicines combined into one pill or package. True, this packaging is convenient– but you can often save money by buying your medicine as its separate components. Let’s look at some examples:

Lotrel blood pressure pills. This is actually a combination of two blood pressure medicines: amlodipine and benazapril. Lotrel, the combo pill, is available in a generic form, as are it’s two individual ingredients.

However, the pricing works out as follows (Costco prices):

Lotrel 10/20 (generic), 30 tabs: $70

VS

Amlodipine 10 mg, 30 tabs: $6

Benazepril 20 mg, 30 tabs: $6

Total: $12

I am really not sure the reason for this price disparity but I have some inklings.

I know that Big Pharma (BP) releases their combo products long after the original medication has been released. Usually by adding a little bit of diuretic, or in this case the amlodipine, a calcium channel blocker. This enables BP to get a brand new patent for these combo pills. So they are able to keep the combo pill price high long after the individual ingredient prices go generic and become much cheaper.

In the case of Lotrel, while the combo pill is also technically generic, its makers may be enjoying the one year manufacturing exclusivity that keeps generic prices initially high. Or it may be an expensive manufacturing process– but why pay for that?

Moving on to my latest favorite outrage:

Prevpac, a treatment for H.pylori. H.pylori is the bacteria that can cause ulcers and gastritis. Prevpacs are a two week treatment course of three different medicines all prepackaged for you. For us docs they are super easy to order. However, Prevpacs are not generic, but the three components of Prevpac ARE available as generic. Let’s look at how the pricing shakes out:

Prevpac, 2 week supply: $396

VS

amoxicillin 500 mg, 4 tabs x 2 weeks- $8

clarithromycin 500 mg, 2 tabs x 2 weeks- $17

lansoprazole 30 mg, 2 tabs x 2 weeks- $63

Total of the three components: $88

ADVERTISEMENT

These are just two examples of how buying prescriptions “a la carte” saves you big money over medicine “combo platters”. Ask your doctor if you are on any of these combination treatments and see if there might be a cheaper alternative.

Leslie Ramirez is an internal medicine physician and founder of Leslie’s List, which provides information that enables all patients, but especially the uninsured and underinsured, to find more affordable medications and health care services.

Submit a guest post and be heard.

Prev

MKSAP: 68-year-old woman with difficulty seeing out of her left eye

July 7, 2010 Kevin 1
…
Next

Emergency room waits grow as more people become insured

July 8, 2010 Kevin 7
…

Tagged as: Medications

Post navigation

< Previous Post
MKSAP: 68-year-old woman with difficulty seeing out of her left eye
Next Post >
Emergency room waits grow as more people become insured

ADVERTISEMENT

More by Leslie Ramirez, MD

  • a desk with keyboard and ipad with the kevinmd logo

    Why are some generic drugs so expensive?

    Leslie Ramirez, MD
  • a desk with keyboard and ipad with the kevinmd logo

    Options when your drug copays are too expensive

    Leslie Ramirez, MD
  • a desk with keyboard and ipad with the kevinmd logo

    Where an adult can get low cost vaccines

    Leslie Ramirez, MD

More in Meds

  • The unfair war on buprenorphine

    Brian Lynch, MD
  • Drug giants face suit over hidden cancer risks

    Martha Rosenberg
  • The diseconomics of scale: How Indian pharma’s race to scale backfires on U.S. patients

    Adwait Chafale
  • A psychiatrist’s 20-year journey with ketamine

    Muhamad Aly Rifai, MD
  • How drug companies profit by inventing diseases

    Martha Rosenberg
  • Every medication error is a system failure, not a personal flaw

    Muhammad Abdullah Khan
  • Most Popular

  • Past Week

    • Why doctors must fight for a just health care system

      Alankrita Olson, MD, MPH & Ashley Duhon, MD & Toby Terwilliger, MD | Policy
    • The ignored clinical trials on statins and mortality

      Larry Kaskel, MD | Conditions
    • Why medicine needs a second Flexner Report

      Robert C. Smith, MD | Physician
    • Why Hollywood’s allergy jokes are dangerous

      Lianne Mandelbaum, PT | Conditions
    • From a 494 MCAT to medical school success

      Spencer Seitz | Education
    • What Beauty and the Beast taught me about risk

      Jayson Greenberg, MD | Physician
  • Past 6 Months

    • Health equity in Inland Southern California requires urgent action

      Vishruth Nagam | Policy
    • How restrictive opioid policies worsen the crisis

      Kayvan Haddadan, MD | Physician
    • Why doctors must fight for a just health care system

      Alankrita Olson, MD, MPH & Ashley Duhon, MD & Toby Terwilliger, MD | Policy
    • Why primary care needs better dermatology training

      Alex Siauw | Conditions
    • The ignored clinical trials on statins and mortality

      Larry Kaskel, MD | Conditions
    • Why medical notes have become billing scripts instead of patient stories

      Sriman Swarup, MD, MBA | Tech
  • Recent Posts

    • From a 494 MCAT to medical school success

      Spencer Seitz | Education
    • It’s time to operationalize physician wellness

      Muhamad Aly Rifai, MD | Conditions
    • The science behind my son’s sensory overload

      Carrie Friedman, NP | Conditions
    • What patients do not see behind the white coat

      Zaid Mahmood, MD | Physician
    • The unfair war on buprenorphine

      Brian Lynch, MD | Meds
    • Why U.S. health care pricing confusion demands bold solutions [PODCAST]

      The Podcast by KevinMD | Podcast

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 5 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Why doctors must fight for a just health care system

      Alankrita Olson, MD, MPH & Ashley Duhon, MD & Toby Terwilliger, MD | Policy
    • The ignored clinical trials on statins and mortality

      Larry Kaskel, MD | Conditions
    • Why medicine needs a second Flexner Report

      Robert C. Smith, MD | Physician
    • Why Hollywood’s allergy jokes are dangerous

      Lianne Mandelbaum, PT | Conditions
    • From a 494 MCAT to medical school success

      Spencer Seitz | Education
    • What Beauty and the Beast taught me about risk

      Jayson Greenberg, MD | Physician
  • Past 6 Months

    • Health equity in Inland Southern California requires urgent action

      Vishruth Nagam | Policy
    • How restrictive opioid policies worsen the crisis

      Kayvan Haddadan, MD | Physician
    • Why doctors must fight for a just health care system

      Alankrita Olson, MD, MPH & Ashley Duhon, MD & Toby Terwilliger, MD | Policy
    • Why primary care needs better dermatology training

      Alex Siauw | Conditions
    • The ignored clinical trials on statins and mortality

      Larry Kaskel, MD | Conditions
    • Why medical notes have become billing scripts instead of patient stories

      Sriman Swarup, MD, MBA | Tech
  • Recent Posts

    • From a 494 MCAT to medical school success

      Spencer Seitz | Education
    • It’s time to operationalize physician wellness

      Muhamad Aly Rifai, MD | Conditions
    • The science behind my son’s sensory overload

      Carrie Friedman, NP | Conditions
    • What patients do not see behind the white coat

      Zaid Mahmood, MD | Physician
    • The unfair war on buprenorphine

      Brian Lynch, MD | Meds
    • Why U.S. health care pricing confusion demands bold solutions [PODCAST]

      The Podcast by KevinMD | Podcast

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Combo pills do not save patients money
5 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...